Claims
- 1. The process for producing the compounds described and labeled in the specification as of formula 13G comprising the step of mixing the compounds described and labeled in the specification as of formula 12G with an acrylate ester in the presence of base; whereinR4 is optionally substituted C1-8 alkyl, C3-10 cycloalkyl, lower alkyl-C3-10 cycloalkyl, alkenyl, aryl, substituted aryl, alkylaryl, or substituted alkylaryl; R6 is optionally substituted C1-8 alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl, C3-10 cycloalkyl, lower alkyl-C3-10 cycloalkyl, heteroaryl, or substituted heteroaryl; and R8 is optionally substituted C1-8 alkyl, C3-10 cycloalkyl, lower alkyl-C3-10 cycloalkyl, alkenyl, aryl, substituted aryl, alkylaryl, or substituted alkylaryl.
- 2. The process of claim 1, where the acrylate ester is methyl, ethyl or t-butyl acrylate.
- 3. The process of claim 2, where the base is potassium hydride, sodium hydride, potassium t-butoxide, sodium carbonate, potassium carbonate, cesium carbonate or a teritiary amine, including diisopropylethyl amine, in a polar aprotic solvent such as dimethyl sulfoxide, DMF or acetonitrile.
- 4. The process of claim 1 where the acrylate ester is t-butyl acrylate, the base is cesium carbonate in DMSO and the mixing temperature is between about 20° C. and about 100° C. such that the compounds produced are represented by formulas 13CPT, 13CPT(R), or 13CPT(S) as described and identified in the specification.
- 5. The process for producing the compounds described and labeled in the specification as of formula 14G comprising the step of mixing the compounds described and labeled in the specification as of formula 13G with a strong acid; whereinR6 is optionally substituted C1-8 alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl, C3-10 cycloalkyl, lower alkyl-C3-10 cycloalkyl, heteroaryl, or substituted heteroaryl; and R8 is optionally substituted C1-8 alkyl, C3-10 cycloalkyl, lower alkyl-C3-10 cycloalkyl, alkenyl, aryl, substituted aryl, alkylaryl, or substituted alkylaryl.
- 6. The process according to claim 5 where a solvent is added to the mixture.
- 7. The process according to claim 6 where toluene is the solvent and trifluoroacetic acid is the acid.
- 8. The process according to claim 5 wherein the compound produced is 14CPT and wherein 14CPT is subsequently reacted with the compounds as described and identified in the specification as U-772 and U-908 to produce an unpurified form of CPT-11.
- 9. The process according to claim 8 comprising the additional step of purifying the unpurified form of CPT-11 to produce a purified form of CPT-11.
Parent Case Info
This application is a divisional of U.S. application Ser. No. 09/511,006, filed Feb. 22, 2000, now U.S. Pat. No. 6,235,907 which is a divisional of U.S. application Ser. No. 09/230,245, filed Oct. 2, 1997, now U.S. Pat. No. 6,121,451 which is the national phase of International Application No. PCT/US96/04163, International Filing Date Apr. 1, 1996, now U.S. Pat. No. 6,121,451, which is a continuation-in-part of U.S. application Ser. No. 08/419,643, filed Apr. 7, 1995, now abandoned.
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
4778891 |
Tagawa et al. |
Oct 1988 |
A |
4894456 |
Wall et al. |
Jan 1990 |
A |
5053512 |
Wani et al. |
Oct 1991 |
A |
5405963 |
Fortunak et al. |
Apr 1995 |
A |
Foreign Referenced Citations (3)
Number |
Date |
Country |
0 220 601 |
Oct 1986 |
EP |
9003169 |
Apr 1990 |
WO |
WO 9429310 |
Dec 1994 |
WO |
Non-Patent Literature Citations (4)
Entry |
M. Shamma, D.A. Smithers, V. St. George, Tetrahedron, 1973, 1949-1954. |
H. Terasawa, M. Sugimori, A. Ejima, H. Tagawa, Chem. Pharm. Bull., 1989, 37, 3382-3385. |
A. Ejima, H. Terasawa, M. Sugimori, H. Tagawa, J.C.S. Perkin I, 1990, 27-31. |
M.C. Wani, A.W. Nicholas, M.E. Wall J. Med. Chem. 1987, 2317-2319. |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
08/419643 |
Apr 1995 |
US |
Child |
09/230245 |
|
US |